584 related articles for article (PubMed ID: 19222427)
1. The undesirable effects of neuromuscular blocking drugs.
Claudius C; Garvey LH; Viby-Mogensen J
Anaesthesia; 2009 Mar; 64 Suppl 1():10-21. PubMed ID: 19222427
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular blocking drugs and their antagonists in patients with organ disease.
Craig RG; Hunter JM
Anaesthesia; 2009 Mar; 64 Suppl 1():55-65. PubMed ID: 19222432
[TBL] [Abstract][Full Text] [Related]
3. Basic principles of neuromuscular transmission.
Martyn JA; Fagerlund MJ; Eriksson LI
Anaesthesia; 2009 Mar; 64 Suppl 1():1-9. PubMed ID: 19222426
[TBL] [Abstract][Full Text] [Related]
4. Postoperative residual curarisation: complication or malpractice?
Cammu G
Acta Anaesthesiol Belg; 2004; 55(3):245-9. PubMed ID: 15515302
[TBL] [Abstract][Full Text] [Related]
5. Residual neuromuscular blockade in critical care.
Wilson J; Collins AS; Rowan BO
Crit Care Nurse; 2012 Jun; 32(3):e1-9; quiz e10. PubMed ID: 22661165
[TBL] [Abstract][Full Text] [Related]
6. Adverse effects of neuromuscular blockers and their antagonists.
Naguib M; Magboul MM
Middle East J Anaesthesiol; 1998 Jun; 14(5):341-73. PubMed ID: 9785339
[TBL] [Abstract][Full Text] [Related]
7. Applied pharmacology of common neuromuscular blocking agents in critical care.
Prielipp RC; Coursin DB
New Horiz; 1994 Feb; 2(1):34-47. PubMed ID: 7922428
[TBL] [Abstract][Full Text] [Related]
8. Severe drug reactions during anaesthesia.
Bird AG
Adverse Drug React Acute Poisoning Rev; 1987; 6(3):117-40. PubMed ID: 2447764
[No Abstract] [Full Text] [Related]
9. Clinical limitations of acetylcholinesterase antagonists.
Caldwell JE
J Crit Care; 2009 Mar; 24(1):21-8. PubMed ID: 19272535
[TBL] [Abstract][Full Text] [Related]
10. Monitoring neuromuscular block: an update.
Fuchs-Buder T; Schreiber JU; Meistelman C
Anaesthesia; 2009 Mar; 64 Suppl 1():82-9. PubMed ID: 19222435
[TBL] [Abstract][Full Text] [Related]
11. Cyclodextrins and the emergence of sugammadex.
Booij LH
Anaesthesia; 2009 Mar; 64 Suppl 1():31-7. PubMed ID: 19222429
[TBL] [Abstract][Full Text] [Related]
12. How rational is muscle relaxation during cardiac surgery?
Cammu G
Acta Anaesthesiol Belg; 2007; 58(1):7-14. PubMed ID: 17486918
[TBL] [Abstract][Full Text] [Related]
13. Interactions of neuromuscular blocking drugs.
Cammu G
Acta Anaesthesiol Belg; 2001; 52(4):357-63. PubMed ID: 11799568
[TBL] [Abstract][Full Text] [Related]
14. A review of neuromuscular blockade in the critically ill patient.
Burry L; HoSang M; Hynes-Gay P
Dynamics; 2001; 12(3):28-33; quiz 34-5. PubMed ID: 11982205
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular blockade in adult intensive care.
Topulos GP
New Horiz; 1993 Aug; 1(3):447-62. PubMed ID: 7922424
[TBL] [Abstract][Full Text] [Related]
16. Practical points in understanding neuromuscular blockade.
Steckbar T
J Post Anesth Nurs; 1990 Oct; 5(5):350-3. PubMed ID: 2213630
[TBL] [Abstract][Full Text] [Related]
17. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period.
Murphy GS
Minerva Anestesiol; 2006 Mar; 72(3):97-109. PubMed ID: 16493386
[TBL] [Abstract][Full Text] [Related]
18. Muscle relaxants and reversal agents.
Van Sickel AD; Spadaccia K
Crit Care Nurs Clin North Am; 1991 Mar; 3(1):151-8. PubMed ID: 2043325
[TBL] [Abstract][Full Text] [Related]
19. Preclinical pharmacology of sugammadex.
Bom A; Hope F; Rutherford S; Thomson K
J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
[TBL] [Abstract][Full Text] [Related]
20. [Systemic allergic reactions precipitated by neuromuscular blocking agents].
Andersen PT; Mølgaard J
Ugeskr Laeger; 1985 Dec; 147(51):4181-3. PubMed ID: 4090060
[No Abstract] [Full Text] [Related]
[Next] [New Search]
